MARTIGNONI, EMILIA SILVANA
 Distribuzione geografica
Continente #
NA - Nord America 5.191
EU - Europa 3.290
AS - Asia 520
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
Totale 9.017
Nazione #
US - Stati Uniti d'America 5.183
IT - Italia 1.714
UA - Ucraina 614
SE - Svezia 284
TR - Turchia 241
IE - Irlanda 193
VN - Vietnam 166
FI - Finlandia 160
GB - Regno Unito 143
DE - Germania 104
CN - Cina 71
FR - Francia 31
IN - India 24
BE - Belgio 20
JP - Giappone 8
EU - Europa 6
CA - Canada 5
NL - Olanda 4
NZ - Nuova Zelanda 4
SG - Singapore 4
AU - Australia 3
ES - Italia 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BG - Bulgaria 2
BR - Brasile 2
DK - Danimarca 2
HR - Croazia 2
IL - Israele 2
RU - Federazione Russa 2
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GL - Groenlandia 1
GR - Grecia 1
HU - Ungheria 1
IM - Isola di Man 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
Totale 9.017
Città #
Milan 1.299
Fairfield 795
Chandler 587
Jacksonville 462
Woodbridge 442
Seattle 371
Ashburn 360
Houston 324
Wilmington 301
Ann Arbor 253
Cambridge 250
Dublin 192
Princeton 154
Izmir 145
Nyköping 144
Dong Ket 88
San Mateo 77
Como 70
Rome 69
Dearborn 60
San Diego 43
Ogden 33
Philadelphia 30
Boardman 27
Norwalk 20
Brussels 18
Düsseldorf 18
Pune 16
Edinburgh 13
Los Angeles 13
Verona 11
Kunming 9
Beijing 8
Tokyo 8
Hefei 7
Nanchang 7
Nanjing 7
Auburn Hills 6
Helsinki 6
Chicago 5
London 5
New York 5
Fuzhou 4
Jinan 4
Amsterdam 3
Chengdu 3
Chongqing 3
Frankfurt am Main 3
Guangzhou 3
Kocaeli 3
Madrid 3
Miami 3
Redwood City 3
Washington 3
Atlanta 2
Auckland 2
Brisbane 2
Charlotte 2
Copenhagen 2
Dallas 2
Dubai 2
Flushing 2
Fort Worth 2
Hebei 2
Mountain View 2
Paris 2
Redmond 2
Singapore 2
Sofia 2
Stockholm 2
São Paulo 2
Tel Aviv 2
Toronto 2
Vienna 2
Xian 2
Zagreb 2
Acton 1
Athens 1
Berlin 1
Bucharest 1
Budapest 1
Castelnuovo Rangone 1
Catania 1
Changsha 1
Chaoyang 1
Chiswick 1
Cormeilles-en-Parisis 1
Dambulla 1
Darwen 1
Douglas 1
Dromcollogher 1
Dunedin 1
Glasgow 1
Greensboro 1
Groningen 1
Hastings 1
Highland Park 1
Hounslow 1
Islington 1
Istanbul 1
Totale 6.864
Nome #
Calcium homeostasis is dysregulated in parkinsonian patients with l-DOPA-induced dyskinesias 172
5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms 160
Disordered pupil reactivity in Parkinson's disease. 154
Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome. 151
Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants. 146
The association of menstrual migraine with the premenstrual syndrome. 140
The brain as a target for adrenocortical steroids: cognitive implications. 139
CARDIOVASCULAR AUTONOMIC MODULATION AND ACTIVITY OF CAROTID BARORECEPTORS AT ALTITUDE. 139
Changes of neuroendocrine axes in patients with menstrual migraine. 137
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 137
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type. 135
High-dose ropinirole in advanced Parkinson's disease with severe dyskinesias. 135
Free plasma catecholamine levels in healthy subjects: a basal and dynamic study.The influence of age. 134
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA. 134
Platelet catecholamines in cluster headache. 133
BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease 133
Nocturnal sleep in multisystem atrophy with autonomic failure: polygraphic findings in ten patients. 132
Is seborrhea a sign of autonomic impairment in Parkinson's disease? 132
Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo. 131
Autonomic regulation of heart rate and peripheral circulation: comparison of high altitude and sea level residents. 131
Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women. 130
Functional changes of the basal ganglia circuitry in Parkinson's disease. 130
Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl. 129
Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale. 128
Non-hormonal therapy of premenstrual syndrome. 128
Combined response of plasma and platelet catecholamines to different types of short-term stress. 128
Pituitary-adrenal responses to dexamethasone and CRH administration in patients with untreated Parkinson's disease. 128
Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. 128
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease. 127
Determination of hydroxyl free radical formation in human platelets using high-performance liquid chromatography with electrochemical detection. 126
Effects of etoperidone on sympathetic and pituitary-adrenal responses to diverse stressors in humans. 125
"Off" painful dystonia in Parkinson's disease treated with botulinum toxin. 125
Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. 124
Modifications of local cerebral metabolic rates for glucose and motor behavior in rats with unilateral lesion of the subthalamic nucleus. 123
Sleep attacks in Parkinson's disease: a clinical and polysomnographic study. 122
Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease 122
The role of language areas in motor control dysfunction in Parkinson's disease. 121
Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection. 121
Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease. 121
An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics. 121
Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter study. 121
Terguride in fluctuating parkinsonian patients: a double-blind study versus placebo. 120
Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients 120
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment 120
LISURIDE PLUS SELEGILINE IN THE TREATMENT OF EARLY PARKINSON'S DISEASE. 118
Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. 118
Parkinson's disease and reproductive life events. 117
Medical healthcare use in Parkinson’s disease: survey in a cohort of ambulatory patients in Italy. 116
Motor complications of Parkinson's disease. 114
Changes in motoneuron excitability of masseter muscle following exteroceptive stimuli in Parkinson's disease. 114
Hashimoto's thyroiditis in association with Tolosa Hunt syndrome: a case report. 114
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease. 114
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter,crossover, controlled study. 113
Premenstrual dysphoric disorder and eating disorders. 112
The influence of gender in the evaluation of platelet and plasma catecholamines. 112
Expression polymorphism of the blood-brain barrier component P-glycoprotein(MDR1) in relation to Parkinson's disease. 110
Active music therapy in Parkinson's disease: an integrative method for motor and emotional rehabilitation. Psychosom Med. 2000 May-Jun;62(3):386-93. 110
The autonomic nervous system and hypoxia: mountain medicine. 107
Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease. 106
Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation. 105
Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol. 2000 Sep;62(1):63-88. 100
Electrophysiological study on jaw-opening reflex recorded from digastric muscle in Parkinson's disease and primary cranial dystonias. 99
Terguride in stable Parkinson's disease. 94
CARDIOPRESSOR EFFECTS OF SHORT-TERM TREATMENT WITH CABERGOLINE IN L-DOPA STABLE RESPONDER PARKINSONIAN PATIENTS: RELEVANCE OF POSTPRANDIAL HYPOTENSION. 91
Active music therapy and Parkinson's disease: methods. 89
LISURIDE AND BROMOCRYPTINE IN L-DOPA STABLE-RESPONDER PARKINSONIAN PATIENTS: A COMPARATIVE, DOUBLE-BLIND EVALUATION OF CARDIOPRESSOR AND NEUROCHEMICAL EFFECTS. 89
Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism. 89
The effects of physical exercise at high altitude on adrenocortical function in humans. 85
Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson's disease 85
ALTITUDE, EXERCISE, AND MOUNTAIN MEDICINE: LESSONS FROM THE FIELD. 84
Reproductive life milestones in women with Parkinson's disease. 81
Autonomic disorders in Parkinson's disease. 80
Dihydroergocryptine in the treatment of Parkinson's disease: a six months' double-blind clinical trial. 79
COMT inhibition and safety. 76
Further characterization of autonomic involvement in multiple system atrophy: a pupillometric study. 74
Parkinson's Disease Comorbidity Study Group. Comorbid disorders and hospitalisation in Parkinson's disease: a prospective study. 73
Evidence of alpha-N-acetyl beta-endorphin in human cerebrospinal fluid. 71
Totale 9.032
Categoria #
all - tutte 24.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.721


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.936 102 82 99 422 126 170 208 234 153 127 38 175
2020/20211.280 42 143 63 145 82 145 49 101 186 49 109 166
2021/2022824 93 66 80 112 12 46 28 38 30 116 62 141
2022/20231.405 104 89 219 128 93 302 0 172 165 46 59 28
2023/20241.987 342 358 334 355 361 88 6 69 47 14 2 11
Totale 9.032